EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Direct questions

29. Which GLP-1 pharmacy contract terms deserve the most attention?

Dose Diligence research deskSection 01 · Page 29 of 34Last updated 17 Nov 2026

Prioritize terms that prevent stranded commitments and make failure or transition manageable. Price protection is incomplete if the clinic remains locked in after the arrangement can no longer serve its intended patients.

Proposed negotiation agenda—not model legal clauses:

ClauseBuyer objective
Product and facility scheduleIdentify permitted products, presentations and performing entities
SubcontractingNotice and review of material facility or fulfilment changes
Regulatory changeSuspension, termination and orderly transition mechanisms
PricingClear fees, programme dependencies and notice of changes
Minimum commitmentsRamp periods and relief for documented access or service failures
Service failuresCorrective action, meaningful remedies and termination rights
Quality and recallsResponsibilities, records, notification and cost allocation
DataAccess, permitted use, security and exportability
PrepaymentsReconciliation, unused balances and refund treatment
ExitAssistance, records, outstanding orders and patient communications
Insurance and liabilityCoverage matched to the actual activities and risks

Manufacturer offer terms can reserve amendment or termination rights. A pharmacy agreement should therefore explain what happens if the underlying offer changes, rather than implying that the clinic has secured a fixed patient price. (zepbound.lilly.com)

Have counsel review enforceability, liability allocation and state-specific requirements before signature.

Explore the table row by row

A working view of the research

Product and facility schedule

Buyer objective
Identify permitted products, presentations and performing entities

Sources cited on this page

  1. zepbound.lilly.com · Source 1 ↗https://zepbound.lilly.com/hcp/coverage-savings
Section sources →